E. Lundström

发表

Estrone – a partial estradiol antagonist in the normal breast

K. Carlström, P. Conner, E. Lundström, 2015, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Progestogen addition with low-dose levonorgestrel intrauterine system in menopausal hormone treatment gives less normal breast tissue proliferation than oral norethisterone acetate or medroxyprogesterone acetate

E. Lundström, G. Söderqvist, Ivana Virijevic, 2020, Hormone molecular biology and clinical investigation.

Hormone replacement therapy and mammographic breast density

E. Lundström, B. Schoultz, 2020 .

Expression of syndecan-1 in histologically normal breast tissue from postmenopausal women with breast cancer according to mammographic density

K. Sandelin, L. Skoog, B. V. VON Schoultz, 2006, Climacteric : the journal of the International Menopause Society.

Mammographic breast density during hormone replacement therapy: differences according to treatment.

B. V. VON Schoultz, B. Wilczek, B Wilczek, 1999, American journal of obstetrics and gynecology.

Dehydroepiandrosterone and/or its metabolites: possible androgen receptor antagonistic effects on digitized mammographic breast density in normal breast tissue of postmenopausal women

K. Carlström, E. Lundström, S. Naessén, 2018, Hormone molecular biology and clinical investigation.

Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density.

B. V. VON Schoultz, E. Azavedo, G. Svane, 2002, American journal of obstetrics and gynecology.

Effects of Estradiol/Micronized Progesterone vs. Conjugated Equine Estrogens/Medroxyprogesterone Acetate on Breast Cancer Gene Expression in Healthy Postmenopausal Women

E. Tani, E. Lundström, G. Söderqvist, 2023, International journal of molecular sciences.

Effects of drospirenone and norethisterone acetate combined with estradiol on mammographic density and proliferation of breast epithelial cells-A prospective randomized trial.

K. Brismar, A. Hirschberg, E. Tani, 2019, Maturitas.

Effects of percutaneous estradiol-oral progesterone versus oral conjugated equine estrogens-medroxyprogesterone acetate on breast cell proliferation and bcl-2 protein in healthy women.

K. Leifland, P. Conner, E. Tani, 2011, Fertility and sterility.

Digitized assessment of mammographic breast density in patients who received low-dose intrauterine levonorgestrel in continuous combination with oral estradiol valerate: a pilot study.

L. Skoog, M. Olovsson, B. V. VON Schoultz, 2006, Fertility and sterility.

Testosterone addition during menopausal hormone therapy: effects on mammographic breast density

B. V. VON Schoultz, A. Hirschberg, E. Azavedo, 2007, Climacteric : the journal of the International Menopause Society.

Digitized assessment of mammographic breast density--effects of continuous combined hormone therapy, tibolone and black cohosh compared to placebo.

A. Hirschberg, E. Lundström, G. Söderqvist, 2011, Maturitas.

Neutral effect of ultra-low-dose continuous combined estradiol and norethisterone acetate on mammographic breast density

B. V. VON Schoultz, E. Azavedo, G. Svane, 2007, Climacteric : the journal of the International Menopause Society.

Breast cancer and hormonal therapy.

B. V. VON Schoultz, P. Conner, E. Lundström, 2008, Clinical obstetrics and gynecology.

Percutaneous estradiol/oral micronized progesterone has less-adverse effects and different gene regulations than oral conjugated equine estrogens/medroxyprogesterone acetate in the breasts of healthy women in vivo

K. Leifland, E. Lundström, G. Söderqvist, 2012, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens

B. V. VON Schoultz, B. Wilczek, E. Lundström, 2001, Climacteric : the journal of the International Menopause Society.